2017 10 04 Use of Psilocybin-Assisted Psychotherapy to treat Patients with Existential Distress Associated with a Cancer Diagnosis PSYCHIATRY CONFERENCE
Title: Use of Psilocybin-Assisted Psychotherapy to treat Patients with Existential Distress Associated with a Cancer Diagnosis
Gabrielle Agin-Liebes, MA; Dept of Psychiatry,
Richmond Psychiatry Department
Resources: See PowerPoint Presentation Slides
Statement of Disclosure:
The Kaiser Permanente East Bay Richmond Medical Center has determined that the speakers and the planning committee for this program do not have affiliations with any corporate organizations that may constitute a conflict of interest with this program. Kaiser Permanente does not endorse any brand name products.
East Bay Area - Richmond is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
East Bay Area - Richmond designates this live activity for a maximum of 1.0 AMA PRA Category 1 credit(s)TM.. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses may report 1 hour of credit towards the continuing medical education requirements for license renewal by the California Board of Registered Nurses.
Psychiatry Department staff, Specialist and other interested clinicians are invited to attend within their scope of practice where applicable.
As a result of this session, participants will be able to:
- Summarize history of clinical trials utilizing classic hallucinogens with individuals suffering from anxiety stemming from terminal illness.
- Describe study design and methodology of recently published randomized double-blind controlled studies of psilocybin-assisted psychotherapy in patients with life-threatening cancer.
- Discuss prevailing theories regarding therapeutic mechanisms of action and phenomenological characteristics of psilocybin-assisted psychotherapy.
- 1.00 AMA PRA Category 1 Credit(s)™